Literature DB >> 21393871

A cytohistological study of Ki-67 expression in ovarian tumors.

Monisha Choudhury1, Seema Goyal, Mukta Pujani.   

Abstract

BACKGROUND AND
OBJECTIVE: The study was conducted to evaluate the diagnostic accuracy of imprint cytology in ovarian neoplasms, and to investigate the biological significance of Ki-67 antigen expression in benign and malignant ovarian tumors and correlate it with histological type, grade, and stage of malignant tumor.
MATERIALS AND METHODS: A total of 50 cases including 25 prospective and 25 retrospective cases were studied. Imprint cytology was performed on 25 ovarian tumors and compared with histopathological diagnosis. Ki-67 immunohistochemistry was performed on all 50 cases.
RESULTS: On immunohistochemistry, benign tumors had a mean Ki-67 index of 3.2 ± 3.7 while malignant tumors had a mean Ki-67 index of 33.1 ± 16.7, the difference being statistically significant. Significant correlation was observed between the Ki-67 index and stage of the tumor; however, there was no correlation between the grade of differentiation and histological type of tumor with the Ki-67 index.
CONCLUSIONS: In the present study, the Ki-67 index was higher in advanced stage tumors; hence a higher Ki-67 index points toward the aggressive behavior and poorer clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393871     DOI: 10.4103/0377-4929.77318

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Diagnostic and Prognostic Significance of Ki-67 Immunohistochemical Expression in Surface Epithelial Ovarian Carcinoma.

Authors:  Asha Mahadevappa; Shruthi Mysore Krishna; Manjunath Gubbanna Vimala
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Mammary serine protease inhibitor and CD138 immunohistochemical expression in ovarian serous and clear cell carcinomas.

Authors:  Eiman Adel Hasby
Journal:  Tumour Biol       Date:  2015-11-03

3.  VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms.

Authors:  Sudeshna Mukherjee; Mallika Pal; Susmita Mukhopadhyay; Indranil Das; Rathin Hazra; Suman Ghosh; Rajib Kumar Mondal; Runa Bal
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer.

Authors:  Surrin S Deen; Andrew N Priest; Mary A McLean; Andrew B Gill; Cara Brodie; Robin Crawford; John Latimer; Peter Baldwin; Helena M Earl; Christine Parkinson; Sarah Smith; Charlotte Hodgkin; Ilse Patterson; Helen Addley; Susan Freeman; Penny Moyle; Mercedes Jimenez-Linan; Martin J Graves; Evis Sala; James D Brenton; Ferdia A Gallagher
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.